Correlations between Longitudinal Changes in Transitional Zone Volume and Measures of Benign Prostatic Hyperplasia in a Population-Based Cohort

European Urology

Volumn 50, Issue 1, 2006, Pages 105-111

  St Sauver, Jennifer L ^a   Jacobson, Debra J ^a   Girman, Cynthia J ^b   McGree, Michaela E ^a   Lieber, Michael M ^a   Jacobsen, Steven J ^a  

^a Mayo Clinic   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Benign prostatic hyperplasia; Longitudinal outcomes; Population based cohort; Transition zone volume

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROSTATE HYPERTROPHY; QUESTIONNAIRE; SEX ROLE; UNITED STATES; URINE FLOW RATE;

COHORT STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; URINATION DISORDERS;

EID: 33744934748     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.01.013     Document Type: Article

References (23)

1. Emberton M., Andriole G.L., de la Rosette J., et al. Benign prostatic hyperplasia: a progressive disease of aging men. Urology 61 (2003) 267-273
2. Wei JT, Calhoun EA, Jacobsen SJ. Benign prostatic hyperplasia. In Litwin MS, Saigal CS, editors. Urologic Diseases in America. Washington, D.C.: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Government Publishing Office, NIH Publication No. 04-5512; 2004:43-67.
3. Madersbacher S., Alivizatos G., Nordling J., Sanz C.R., Emberton M., and de la Rosette J.J. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46 (2004) 547-554
4. Girman C.J., Jacobsen S.J., Guess H.A., et al. Natural history of prostatism: Relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 153 (1995) 1510-1515
5. Kaplan S.A., Te A.E., Pressler L.B., and Olsson C.A. Transition zone index as a method of assessing benign prostatic hyperplasia: Correlation with symptoms, urine flow and detrusor pressure. J Urol 154 (1995) 1764-1769
6. Tewari A., Shinohara K., and Narayan P. Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients. Urology 45 (1995) 258-264 discussion 265
7. Kurita Y., Ushiyama T., Suzuki K., Fujita K., and Kawabe K. Transition zone ratio and prostate-specific antigen density: the index of response of benign prostatic hypertrophy to an alpha blocker. Int J Urol 3 (1996) 361-366
8. Kurita Y., Masuda H., Terada H., Suzuki K., and Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 51 (1998) 595-600
9. Witjes W.P., Aarnink R.G., Ezz-el-Din K., Wijkstra H., Debruyne E.M., and de la Rosette J.J. The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms. Br J Urol 80 (1997) 84-90
10. Corica F.A., Jacobsen S.J., King B.F., et al. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community-dwelling men. J Urol 161 (1999) 831-834
11. Chute C.G., Panser L.A., Girman C.J., et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150 (1993) 85-89
12. Jacobsen S.J., Guess H.A., Panser L., et al. A population-based study of health care-seeking behavior for treatment of urinary symptoms: The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med 2 (1993) 729-735
13. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 270 (1993) 860-864
14. Barry M.J., Fowler F.J.J., O'Leary M.P., et al. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 148 (1992) 1549-1557
15. Epstein R.S., Deverka P.A., Chute C.G., et al. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 45 (1992) 1431-1445
16. Roberts R.O., Jacobson D.J., Girman C.J., et al. Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia. Am J Epidemiol 157 (2003) 784-791
17. Roberts R.O., Jacobsen S.J., Jacobson D.J., Rhodes T., Girman C.J., and Lieber M.M. Longitudinal changes in peak urinary flow rates in a community based cohort. J Urol 163 (2000) 107-113
18. Jacobsen S.J., Jacobson D.J., Girman C.J., et al. Natural history of prostatism: Risk factors for acute urinary retention. J Urol 158 (1997) 481-487
19. Rhodes T., Girman C.J., Jacobsen S.J., Roberts R.O., Guess H.A., and Lieber M.M. Longitudinal prostate growth rates during 5 years in randomly selected community men 40-79 years old. J Urol 161 (1999) 1174-1179
20. St. Sauver J.L., Jacobson D.J., Girman C.J., Lieber M.M., McGree M.E., and Jacobsen S.J. Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population-based cohort. J Urol 175 (2006) 1018-1022
21. Kaplan S.A., Reis R.B., Staimen V.B., and Te A.E. Is the ratio of transition zone to total prostate volume higher in African-American men than in their Caucasian or Hispanic counterparts?. Br J Urol 82 (1998) 804-807
22. Choi J., Ikeguchi E.F., Lee S.W., Choi H.Y., Te A.E., and Kaplan S.A. Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index?. Eur Urol 42 (2002) 7-11
23. Gades N.M., Jacobson D.J., McGree M.E., Lieber M.M., Roberts R.O., Girman C.J., et al. Determinants of dropout in a longitudinal cohort study of urologic disease in community-based men. Ann Epidemiol 14 (2004) 599